NACDS Applauds DEA Guidance on Forwarding of Electronic Prescriptions for Controlled Substances Key aspect of NACDS Regulatory Reform Initiative will benefit patients and enhance use of e-prescribing to prevent drug abuse and diversion

2017-07-21T07:57:33+00:00Jul-21-17|Categories: Press Release|Tags: , |

NACDS applauds guidance provided this week by the Drug Enforcement Administration (DEA) that addresses a priority of NACDS’ Regulatory Reform Initiative, and that simultaneously benefits patient care and the prevention of drug abuse and diversion.

NACDS Submits Comments to President’s Commission on Combating Drug Addiction and the Opioid Crisis Describes pharmacy as working partner for solutions

2017-08-09T12:19:18+00:00Jul-10-17|Categories: Press Release|Tags: , , |

NACDS President and CEO Steven C. Anderson, IOM, CAE, submitted official comments to the President’s Commission on Combating Drug Addiction and the Opioid Crisis, which reflect NACDS’ commitment to help address prescription drug abuse, addiction and proper access.

With Final Passage, Congress to Send to President NACDS-Backed Drug Abuse, Access Bill Legislation reflects “100-percent commitment to patient care and zero tolerance for abuse”

2017-06-15T16:25:17+00:00Apr-12-16|Categories: Press Release|Tags: , , |

Arlington, Va. – The U.S. House of Representatives today passed the Ensuring Patient Access and Effective Drug Enforcement Act of 2016 (S. 483) in the same version passed by the Senate, making President Obama’s consideration […]

Load More Posts